177 completed, 83 unknown, 35 terminated, 27 withdrawn. 61 Phase 2, 60 Not applicable, 38 Phase 3, 20 Phase 1, 9 Phase 4.
Follow COVID: new trials by email Literature Review of COVID trials Research Report on COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses Investigational IVD for coronaviruses - Coronavirus, Respiratory Infection | Completed | BioFire Defense LLC | 2091 | 2025-09-29 | 2026-08-27 | |
| The Effects of Endotracheal Suctioning on Pain and Serum Markers endotracheal tube suctioning - Intensive Care Unit ICU, Intubation | Not applicable | Recruiting | Loma Linda University | 110 | 2025-01-30 | 2026-07-10 |
| Covid-19 Data Analyses in Brazil Covid | Completed | AstraZeneca | 361000 | 2024-11-12 | 2025-09-18 | |
| Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test Aptitude Medical Systems Metrix COVID Test - COVID-19, COVID | Not applicable | Recruiting | Aptitude Medical Systems | 1000 | 2024-10-17 | 2025-10-02 |
| Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population No Interventions - COVID | Completed | Xijing Hospital | 100 | 2023-11-15 | 2025-01-08 | |
| Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients Pentoxifylline, Placebo - COVID | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2022-11-13 | 2023-01-18 | |
| Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 RESP301 - Pulmonary Complications in Surgical Patients, COVID | Phase 3 | Suspended | University of Birmingham | 6400 | 2022-05-16 | 2025-02-20 |
| Niclosamide In Moderate COVID-19 Niclosamide Oral Tablet, Placebo - COVID | Phase 2 | Withdrawn | Entero Therapeutics | 2022-01-20 | 2022-02-21 | |
| Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo - SARS-CoV 2, COVID | Phase 3 | Withdrawn | APR Applied Pharma Research s.a. | 2021-12-15 | 2026-05-14 | |
| Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer COVID, SARS-CoV 2 | Unknown | Centre Hospitalier le Mans | 2000 | 2021-12-01 | 2022-07-28 | |
| Risk of Air Contamination During Visceral Surgery in COVID19 Patients Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients. - Sars-CoV2, Surgery | Not applicable | Completed | University Hospital, Lille | 2 | 2021-11-16 | 2025-12-23 |
| COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia Helmet Continuous Positive Airway Pressure (CPAP), High Flow Nasal Oxygen (HFNO) - Severe Acute Respiratory Syndrome Coronavirus 2, Hypoxemic Respiratory Failure | Not applicable | Withdrawn | University of Pennsylvania | 2021-11-15 | 2022-04-05 | |
| Detecting SARS-CoV-2 in Tears Tear Collection - COVID, COVID-19 | Completed | University of Minnesota | 7 | 2021-09-01 | 2022-10-31 | |
| Characteristics of Patients With COVID-19 in Meta State, Colombia COVID, SARS-CoV 2 | Withdrawn | Hospital Departamental de Villavicencio | 2021-09-01 | 2023-07-05 | ||
| Outpatient Treatment With Anti-Coronavirus Immunoglobulin Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo - COVID, SARS-CoV2 Infection | Phase 3 | Terminated | University of Minnesota | 741 | 2021-08-06 | 2026-08-13 |
| Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid - COVID | Phase 1 | Unknown | Kafrelsheikh University | 24 | 2021-07-01 | 2021-06-09 |
| Emergency Department (ED) Self-Monitoring Pilot COVID-19 Symptoms entered into the CovidX application - COVID, Covid-19 | Not applicable | Withdrawn | University of Michigan | 2021-06-01 | 2021-07-01 | |
| Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease Maintenance or reduction of immunosuppression - COVID, Kidney Transplant; Complications | Phase 2 / Phase 3 | Withdrawn | Brigham and Women's Hospital | 2021-05-03 | 2022-05-04 | |
| Primary Prevention of Infection by COVID-19 in Workers Group A: oropharygeal spray and immunostimulant emulsion, Group D:Placebo oropharyngeal spray + Placebo taken PO - COVID | Not applicable | Completed | Unidad de Investigación Genética Molecular | 152 | 2021-03-18 | 2021-07-15 |
| Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo - SARS-CoV 2, COVID | Phase 2 / Phase 3 | Terminated | APR Applied Pharma Research s.a. | 144 | 2021-02-15 | 2023-02-03 |
Showing 20 of 345. Sign in to see all of them.
COVID-19 (106) · Coronavirus Infections (76) · Respiratory Distress Syndrome (29) · Pneumonia (16) · Pneumonia, Viral (15) · Severe Acute Respiratory Syndrome (14) · Neoplasms (8) · Anxiety Disorders (7) · Acute Lung Injury (6) · Respiratory Insufficiency (6) · Acute Kidney Injury (5) · Cytokine Release Syndrome (5) · Thrombosis (5) · Virus Diseases (5) · Cardiovascular Diseases (4)
Infections (160) · Respiratory Tract Diseases (158) · Lung Diseases (149) · Virus Diseases (149) · RNA Virus Infections (144) · Nidovirales Infections (142) · Coronaviridae Infections (141) · Respiratory Tract Infections (130) · Pneumonia (108) · Pneumonia, Viral (101) · Coronavirus Infections (66) · Pathological Conditions, Signs and Symptoms (40) · Respiration Disorders (36) · Pathologic Processes (27) · Cardiovascular Diseases (23)
Hydroxychloroquine (12) · Ivermectin (12) · Standard of Care (9) · Surveys and Questionnaires (8) · Azithromycin (6) · Blood Specimen Collection (5) · Chloroquine (5) · Enoxaparin (5) · Zinc (5) · Lopinavir (4) · Vitamin D (4) · Ascorbic Acid (3) · Cholecalciferol (3) · Heparin (3) · Ritonavir (3)
Tanta University (9) · Centre Hospitalier Universitaire de Nice (7) · ProgenaBiome (5) · University of Minnesota (5) · Central Hospital, Nancy, France (4) · Guy's and St Thomas' NHS Foundation Trust (4) · University of Colorado, Denver (4) · Assistance Publique - Hôpitaux de Paris (3) · Henry Ford Health System (3) · Imperial College London (3) · Kanuni Sultan Suleyman Training and Research Hospital (3) · Mansoura University (3) · Max Healthcare Insititute Limited (3) · Tabula Rasa HealthCare (3) · University Hospital Southampton NHS Foundation Trust (3)
United States (84) · France (43) · United Kingdom (38) · Egypt (23) · Italy (23) · Spain (19) · Brazil (14) · Germany (14) · Turkey (Türkiye) (13) · Denmark (11) · Belgium (10) · Canada (9) · India (9) · Switzerland (7) · Australia (6)
Sabine Hazan, MD (5) · Ahmed Samir, MD (2) · Giovanni Salum, MD, PhD (2) · James Neaton, PhD (2) · Jonathan C Javitt, MD, MPH (2) · Nuttha Lumlertgul, MD, PhD (2) · Roman Prymula, Prof. (2) · Sandeep Budhiraja, MRCP, FACP (2) · Sherief Abd-Elsalam, ass. prof. (2) · Veronique Michaud (2) · Adam P Bress, PharmD, MS (1) · Ahmad Ameri, Prof. (1)
PMID 33502773, PMID 34013969, PMID 34473343, PMID 35244208, PMID 36734509, PMID 37162745, PMID 32171076, PMID 32109013, PMID 33177145, PMID 34425070, PMID 36216961, PMID 37489818, PMID 41499179, PMID 12694139, PMID 16287208, PMID 18403664, PMID 19892335, PMID 25108173, PMID 25922396, PMID 26070483, PMID 26271685, PMID 26298866, PMID 27020282, PMID 29650407, PMID 30531947, PMID 30658390, PMID 31668196, PMID 31978945, PMID 31986264, PMID 32000806, PMID 32007143, PMID 32025779, PMID 32031570, PMID 32077115, PMID 32091533, PMID 32101510, PMID 32125452, PMID 32139904, PMID 32146445, PMID 32150360, PMID 32151335, PMID 32179124, PMID 32187459, PMID 32189136, PMID 32204726, PMID 32215581, PMID 32219428, PMID 32220207, PMID 32220208, PMID 32227758